XML 55 R44.htm IDEA: XBRL DOCUMENT v3.26.3
Note 2 - Summary of Significant Accounting Policies (Details Textual)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jun. 28, 2026
USD ($)
shares
Apr. 20, 2026
shares
Mar. 09, 2026
USD ($)
shares
Mar. 09, 2026
USD ($)
shares
Sep. 30, 2026
USD ($)
shares
Mar. 31, 2026
USD ($)
Sep. 30, 2025
USD ($)
Sep. 30, 2026
USD ($)
shares
Sep. 30, 2025
USD ($)
Dec. 31, 2025
USD ($)
shares
Jul. 15, 2026
shares
Jun. 22, 2026
USD ($)
Feb. 06, 2026
USD ($)
Feb. 17, 2025
Revenue from Contract with Customer, Excluding Assessed Tax         $ 1,838,000   $ 0 $ 2,771,000 $ 0          
Number of Reportable Segments               2            
Goodwill         12,161,000     $ 12,161,000   $ 0        
Equity Method Investment, Change in Fair Value         0   0 (2,302,000) 0          
Deferred Stock Issuance Liability, Fair Value Adjustment               160,000            
Intangible Asset, Excluding Goodwill, Impairment Loss               0   $ 0        
Disposal Group, Including Discontinued Operation, Impairment Expenses               12,490,000 0          
Contract with Customer, Asset, after Allowance for Credit Loss         0     0            
Advertising Expense         320,000   0 473,000 0          
KardioNav, Inc. [Member]                            
Short-Term Debt         $ 315,000     $ 315,000            
Cardionomix Inc. [Member]                            
Subsidiary, Ownership Percentage, Parent         82.00%     82.00%           82.00%
Cardionomix Inc. [Member] | Chief Executive Officer and Chairman of the Board [Member]                            
Subsidiary, Ownership Percentage, Parent         12.00%     12.00%            
Cardionomix Inc. [Member] | Certain Third Parties [Member]                            
Subsidiary, Ownership Percentage, Parent         6.00%     6.00%            
KardioNav, Inc. [Member]                            
Subsidiary, Ownership Percentage, Parent                   57.00%        
KardioNav, Inc. [Member] | Chief Executive Officer and Chairman of the Board [Member]                            
Subsidiary, Ownership Percentage, Parent                   10.00%        
KardioNav, Inc. [Member] | Certain Third Parties [Member]                            
Subsidiary, Ownership Percentage, Parent                   33.00%        
QHSLabs Notes [Member]                            
Debt Securities, Realized Gain (Loss)             107,000   117,000          
Discontinued Operations, Held-for-Sale [Member]                            
Disposal Group, Including Discontinued Operation, Impairment Expenses         $ 12,490,000   $ 0 $ 12,490,000 $ 0          
Series C3 Convertible Preferred Stock [Member]                            
Preferred Stock, Stated Value         $ 1,000     $ 1,000            
Preferred Stock, Shares Outstanding (in shares) | shares         2,347     2,347            
Series X Preferred Stock [Member]                            
Preferred Stock, Shares Outstanding (in shares) | shares         0     0   0        
Securities Purchase Agreements [Member]                            
Deferred Stock Issuance Liability $ 600,000       $ 0     $ 0            
Deferred Stock Issuance Liability, Fair Value Adjustment         200,000     200,000            
Securities Purchase Agreements [Member] | Series C3 Convertible Preferred Stock [Member]                            
Preferred Stock, Stated Value 1,000                          
Proceeds from Issuance of Convertible Preferred Stock $ 600,000                          
Stock Obligated to be Issued (in shares) | shares 601                          
Preferred Stock, Shares Issued (in shares) | shares                     601      
Measurement Input, Discount for Lack of Marketability [Member] | Securities Purchase Agreements [Member] | Series C3 Convertible Preferred Stock [Member]                            
Deferred Consideration, Measurement Input 20.00%                          
Valuation Technique, If Converted Model [Member] | Measurement Input, Discount Rate [Member]                            
Deferred Consideration, Measurement Input     20.00% 20.00%                    
FLYTE [Member]                            
Goodwill     $ 9,430,000 $ 9,430,000 12,161,000     12,161,000            
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares (in shares) | shares     5,778                      
Deferred Consideration     $ 5,800,000 $ 5,800,000                 $ 5,300,000  
Equity Method Investment, Change in Fair Value               3,200,000            
FLYTE [Member] | Series D Preferred Stock [Member]                            
Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares (in shares) | shares   11,028   11,028                    
Preferred Stock, Stated Value     $ 1,000 $ 1,000                    
FLYTE [Member]                            
Equity Method Investment, Ownership Percentage     19.98% 19.98%                    
Equity Method Investment, Change in Fair Value           $ (2,300,000)                
Boot Capital Convertible Notes Payable [Member]                            
Long-Term Debt, Gross         0     0            
Notes Payable                       $ 300,000    
May 2025 Notes [Member]                            
Notes Payable         $ 1,400,000     $ 1,400,000            
Customer Concentration Risk [Member] | Revenue Benchmark [Member]                            
Number of Major Customers         1     1            
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Customer One [Member]                            
Concentration Risk, Percentage         14.00%     17.00%            
Customer Concentration Risk [Member] | Accounts Receivable [Member]                            
Number of Major Customers               3   5        
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]                            
Concentration Risk, Percentage               10.00%   27.00%        
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]                            
Concentration Risk, Percentage               14.00%   15.00%        
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]                            
Concentration Risk, Percentage               18.00%            
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three Customers [Member]                            
Concentration Risk, Percentage                   10.00%